Empagliflozin Polpharma

Empagliflozin Polpharma is a medication used to manage type 2 diabetes. It works by helping the kidneys remove excess glucose from the body. This oral medication is manufactured by Zaklady Farmaceutyczne Polpharma S.A. in the EU.

Empagliflozin Polpharma is primarily used to control blood sugar levels in adults with type 2 diabetes. It is often prescribed alongside diet and exercise to improve glycemic control. This medication helps the kidneys remove excess glucose through the urine, which can lower blood sugar levels. Empagliflozin is not typically used for type 1 diabetes or diabetic ketoacidosis.

Common effects of Empagliflozin Polpharma may include increased urination, which helps to remove excess glucose from the body. Some users might experience thirst, dizziness, or urinary tract infections. These effects vary among individuals and are not experienced by everyone who takes the medication.

Empagliflozin Polpharma should be handled with care, especially for those with kidney issues or a history of urinary tract infections. It is important to stay hydrated while taking this medication. Always consult a healthcare provider before starting or stopping any medication.

Empagliflozin Polpharma may interact with certain medications, including diuretics, insulin, and other diabetes medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.